Smith & Nephew (SNN) Other Non-Current Liabilities (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Other Non-Current Liabilities of $82.0 million for Q4 2025, down 24.07% year-on-year from $108.0 million in Q4 2024, and down 12.77% on a QoQ basis from $94.0 million in Q2 2025.
Smith & Nephew (SNN) Other Non-Current Liabilities (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Other Non-Current Liabilities for 17 consecutive years, with $82.0 million the latest figure, recorded in Q4 2025.
- Quarterly Other Non-Current Liabilities fell 24.07% year-over-year to $82.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $82.0 million (down 24.07% YoY) and the FY2025 annual result came in at $82.0 million, down 24.07% from the prior year.
- Other Non-Current Liabilities fell to $82.0 million in Q4 2025 per SNN's latest filing, from $94.0 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for SNN reached as high as $243.0 million in Q4 2022 and fell as low as $35.0 million in Q4 2021.
- A 5-year average of $135.3 million and a median of $108.0 million in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities tumbled 88.1% — and 2022, when it jumped 594.29%.
- Year by year, Other Non-Current Liabilities stood at $35.0 million in 2021, then soared by 594.29% to $243.0 million in 2022, then dropped by 4.12% to $233.0 million in 2023, then tumbled by 53.65% to $108.0 million in 2024, then declined by 24.07% to $82.0 million in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $82.0 million, $94.0 million, and $108.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 82.00 Mn |
| Jun 28, 2025 | 94.00 Mn |
| Dec 31, 2024 | 108.00 Mn |
| Jun 29, 2024 | 152.00 Mn |
| Dec 31, 2023 | 233.00 Mn |
| Dec 31, 2022 | 243.00 Mn |
| Dec 31, 2021 | 35.00 Mn |
| Dec 31, 2020 | 294.00 Mn |
| Jun 30, 2020 | 236.00 Mn |
| Dec 31, 2019 | 214.00 Mn |
| Jun 29, 2019 | 143.00 Mn |
| Dec 31, 2018 | 153.00 Mn |
| Jun 30, 2018 | 137.00 Mn |
| Dec 31, 2017 | 97.00 Mn |
| Dec 31, 2016 | 134.00 Mn |
| Dec 31, 2015 | 193.00 Mn |
| Jun 30, 2015 | 79.00 Mn |
| Dec 31, 2014 | 67.00 Mn |
| Sep 30, 2014 | 83.00 Mn |
| Jun 28, 2014 | 112.00 Mn |